Compliance and Effectiveness of Smoking Cessation Program Started on Hospitalized Patients
1
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Background: Varenicline is now very useful medication for cessation; however, there is only little result of researcheswith varenicline for cessation of hospitalized patients. This research attempted to analyze the cessation effect ofmedication and compliance of hospitalized patients. Methods: This research included data for 52 patients who were prescribed varenicline among 280 patients whowere consulted for cessation during their admission period. This research checked whether smoking was stoppedor not after six months and analyzed their compliance, the factors for succeeding in smoking cessation. Results: One hundred and ninety hospitalized patients participated in smoking cessation counseling among 280patients who included consultation from their admission departments. And varenicline was prescribed for only 80patients after counseling. Nineteen smokers were successful in smoking cessation among 52 final participants representingthe rating of success of 36.5%. The linkage between compliance of varenicline and rate of smoking successfulhas no statistical significance. The factors for succeeding in smoking of hospitalized patients are admissiondepartments, diseases, and economic states. Conclusion: Smoking cessation program has low inpatient compliance. Cooperation of each departments is veryimportant for better compliance. Success rate of cessation was relatively high (36.5%). Cessation attempt duringhospitalization is very effective strategy.
Abstract
Background: Varenicline is now very useful medication for cessation; however, there is only little result of researcheswith varenicline for cessation of hospitalized patients. This research attempted to analyze the cessation effect ofmedication and compliance of hospitalized patients. Methods: This research included data for 52 patients who were prescribed varenicline among 280 patients whowere consulted for cessation during their admission period. This research checked whether smoking was stoppedor not after six months and analyzed their compliance, the factors for succeeding in smoking cessation. Results: One hundred and ninety hospitalized patients participated in smoking cessation counseling among 280patients who included consultation from their admission departments. And varenicline was prescribed for only 80patients after counseling. Nineteen smokers were successful in smoking cessation among 52 final participants representingthe rating of success of 36.5%. The linkage between compliance of varenicline and rate of smoking successfulhas no statistical significance. The factors for succeeding in smoking of hospitalized patients are admissiondepartments, diseases, and economic states. Conclusion: Smoking cessation program has low inpatient compliance. Cooperation of each departments is veryimportant for better compliance. Success rate of cessation was relatively high (36.5%). Cessation attempt duringhospitalization is very effective strategy.
참고문헌 (15)
- How tobacco smoke causes disease: the biology and behavioral basis for smoking-attributable disease: a report of the surgeon general, "U.S. Department of Health and Human Services", U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, ~ (2010)
- The fifth Korea National Health and Nutrition Examination Survey, 2013, "Korean Ministry of Health and Welfare", Korean Ministry of Health and Welfare, ~ (2013)
- Pederson LL, "The effects of counseling on smoking cessation among patients hospitalized with chronic obstructive pulmonary disease: a randomized clinical trial", Int J Addict, 26, pp.107~119 (1991)
- Hennrikus DJ, "The TEAM project: the effectiveness of smoking cessation intervention with hospital patients", Prev Med, 40, pp.249~258 (2005)
- Stewart RB, "Medication compliance in the elderly", Med Clin North Am, 73, pp.1551~1563 (1989)
- Wang C, "Varenicline for smoking cessation: a placebo-controlled, randomized study", Respirology, 14, pp.384~392 (2009)
- Nakamura M, "Efficacy and tolerability of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, in a 12-week, randomized, placebo-controlled, dose-response study with 40-week follow-up for smoking cessation in Japanese smokers", Clin Ther, 29, pp.1040~1056 (2007)
- Tsai ST, "A randomized, placebo-controlled trial of varenicline, a selective alpha-4beta2 nicotinic acetylcholine receptor partial agonist, as a new therapy for smoking cessation in Asian smokers", Clin Ther, 29, pp.1027~1039 (2007)
- Rigotti NA, "Smoking cessation interventions for hospitalized smokers: a systematic review", Arch Intern Med, 168, pp.1950~1960 (2008)
- 정기윤, "입원 환자를 대상으로 한 체계적 금연 교육과 금연 성공률", Korean Journal of Family Medicine, 30(7), pp.503~510 (2009), 대한가정의학회
- 이호, "입원했던 환자의 퇴원 후 흡연율 변화", Korean Journal of Family Medicine, 27(7), pp.556~560 (2006), 대한가정의학회
- Steinberg MB, "Tobacco dependence treatment for hospitalized smokers: a randomized, controlled, pilot trial using varenicline", Addict Behav, 36, pp.1127~1132 (2011)
- 송빛누니, "진료실에서 Varenicline을 이용한 금연성공 요인분석", Korean Journal of Family Medicine, 32(2), pp.112~119 (2011), 대한가정의학회
- 이진영, "Adherence to Varenicline and Abstinence Rates for Quitting Smoking in a Private Health Promotion Center-Based Smoking Cessation Clinic", Tuberculosis and Respiratory Diseases, 72(5), pp.426~432 (2012), 대한결핵및호흡기학회[DOI]
- Suner-Soler R, "Smoking cessation 1 year poststroke and damage to the insular cortex", Stroke, 43, pp.131~136 (2012)